Patents by Inventor Martin Yateman

Martin Yateman has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230233675
    Abstract: The invention relates to treating or preventing anaemia in a subject, such as a mammal or human. In particular, the invention addresses moderate to severe anaemia. Additionally, the invention provides means for sparing administration of erythropoiesis stimulating agents (ESAs) to subjects.
    Type: Application
    Filed: August 11, 2022
    Publication date: July 27, 2023
    Applicant: Kymab Limited
    Inventors: Volker GERMASCHEWSKI, Igor THEURL, Martin YATEMAN, Jasper CLUBE, Steve ARKINSTALL
  • Patent number: 11648308
    Abstract: The invention relates to treating or preventing anaemia in a subject, such as a mammal or human. In particular, the invention addresses moderate to severe anaemia. Additionally, the invention provides means for sparing administration of erythropoiesis stimulating agents (ESAs) to subjects.
    Type: Grant
    Filed: June 1, 2017
    Date of Patent: May 16, 2023
    Assignee: Kymab Limited
    Inventors: Volker Germaschewski, Igor Theurl, Martin Yateman, Jasper Clube, Steve Arkinstall
  • Publication number: 20170319689
    Abstract: The invention relates to treating or preventing anaemia in a subject, such as a mammal or human. In particular, the invention addresses moderate to severe anaemia. Additionally, the invention provides means for sparing administration of erythropoiesis stimulating agents (ESAs) to subjects.
    Type: Application
    Filed: June 1, 2017
    Publication date: November 9, 2017
    Applicant: Kymab Limited
    Inventors: Volker GERMASCHEWSKI, Igor Theurl, Martin Yateman, Jasper Clube, Steve Arkinstall